ADVERTISEMENT
The head of Organigram Global Inc. says the Canadian cannabis company is looking for opportunities to expand its business to new markets after the firm beat revenue expectations in its second fiscal quarter.
Cannabis company Tilray Brands Inc. is proposing a reverse stock split for its shares.
MediPharm Labs Corp. has signed a deal to sell its facility in Hope, B.C., to Rubicon Organics Inc. for $4.5 million in cash.
If it were like most companies on the losing end of a boom and bust cycle, Schwazze could just turn to the US bankruptcy court to keep its creditors at bay while renegotiating its debt. But unlike most businesses, its product — marijuana — is still illegal in the eyes of the federal government.
Aphria Inc. has agreed to pay $30 million to settle a class-action lawsuit by shareholders alleging the company made misrepresentations to capital markets in 2018.
Canopy Growth Corp. reported a loss of $121.9 million in its latest quarter compared with a loss of $216.8 million in the same quarter a year earlier.
The head of Tilray Brands Inc. says he was pleased with the company’s performance in its latest quarter despite tax challenges in the Canadian cannabis market and legalization hurdles in the U.S.
Top picks from Stephen Takacsy, president and CEO, and chief investment officer of Lester Asset Management
Organigram Holdings Inc. says a $90-million deal to buy a cannabis vapes and infused pre-rolls business has made Organigram Canada’s largest recreational pot company by market share.
Canopy Growth Corp. has named Luc Mongeau as the cannabis company’s next chief executive officer.
Shares in Canada’s major cannabis companies fell in early trading after the U.S. election, which saw efforts to legalize recreational cannabis in several states fail.
Florida voters rejected a ballot measure to legalize recreational marijuana, dealing a blow to the cannabis industry and giving a win to the leading opponents: Governor Ron DeSantis and billionaire Ken Griffin.
The head of cannabis-focused consumer packaged goods company Tilray Brands Inc. says he’s “optimistic” about cannabis legalization in the U.S. following next month’s presidential election.
Cannabis company Tilray Brands Inc. reported a loss of US$34.7 million in its first quarter, compared with a loss of US$55.9 million in the same quarter last year, as its net revenue rose 13 per cent.
Uruguay led the world in legalizing marijuana a decade ago, but its dream of building a medical cannabis and hemp powerhouse employing thousands of people with $1 billion in exports is facing a harsh reality check.
The $5 billion industry is under threat as insurers pull out — and the state-created FAIR plan fails to cover growers.
